Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial (Q61713430)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

ChEBI release 2020-05-28

0 references

1 reference

based on heuristic

inferred from title

Clostridium difficile

object named as

Clostridium difficile

1 reference

based on heuristic

inferred from title

Oliver A Cornely

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Derrick W Crook

2

object named as

Derrick W Crook

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Roberto Esposito

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

André Poirier

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michael S Somero

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Karl Weiss

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Pamela Sears

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sherwood Gorbach

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

OPT-80-004 Clinical Study Group

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

8 February 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Lancet Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

281-289

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial-associated risk factors for Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease associated with Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clostridium difficile infection in Europe: a hospital-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing epidemiology of Clostridium difficile infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clostridium difficile ribotypes 001, 017, and 027 are associated with lethal C. difficile infection in Hesse, Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Fidaxomicin versus vancomycin for Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, tolerance, and pharmacokinetic studies of OPT-80 in healthy volunteers following single and multiple oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of strain typing results for Clostridium difficile isolates from North America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970374-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(11)70374-7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22321770%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q61713430&oldid=1983488952"